Evaluating the Effect of a Written Action Plan on Comfort and Understanding of Hidradenitis Suppurativa

This study is being conducted to evaluate if a written action plan for hidradenitis suppurativa (HS) will help patients with hidradenitis suppurativa gain a better understanding of the condition and how to manage the condition on a daily basis compared to a routine verbal consultation.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Hidradenitis Suppurativa Bacterial Infections Bacterial Infections and Mycoses Hidradenitis Infections Skin Diseases Skin Diseases, Bacterial Skin Diseases, Infectious Skin and Connective Tissue Diseases Suppuration Sweat Gland Diseases

Age range

18 year–89 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

University of Arkansas for Medical Sciences

Little Rock, Arkansas, 72205, United States

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

This study will only enroll subjects between the ages of 18-years and 89-years of age.
Diagnosis of HS by a board-certified dermatologist
Able to read and comprehend study materials
No prior exposure to written HS action plans

Exclusion criteria

Those who do not fit the inclusion criteria

Treatment and study plan

Verbal consultation

Behavioral

Verbal consultation only without written information before receiving written action plan

Written Action Plan

Behavioral

Written handout of treatment plan and disease management strategies

Primary outcomes

Visits to High-cost Care Settings [ Time Frame: 1.5 Months ]

Time frame: Through study completion, an average of 1.5 months

Number of visits to ER, urgent care, or hospitalizations because of HS

Sponsors and collaborators

Lead sponsor

University of Arkansas

Other

Registry information

Important dates

Study start: 2020
Primary completion: 2020
Study completion: 2020
First posted: Oct 23, 2020
Registry last updated: Apr 13, 2022

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed